Charles Kunsch
Directeur/Membre du Conseil chez CAPTOR THERAPEUTICS SPOLKA AKCYJNA
Profil
Charles Kunsch's current jobs include being a Board Observer at Kojin Therapeutics, Inc., a Board Member at Endlyz Therapeutics, Inc., a Board Observer at Accent Therapeutics, Inc., a Board Observer at Dg Medicines, a Board Observer at Aquinnah Pharmaceuticals, Inc., a Member of the Board of Trustees at Massachusetts Biomedical Initiatives, a Member of the Supervisory Board at Captor Therapeutics SA, and a Trustee at Penn State Research Foundation.
His former jobs include being a Managing Director at AbbVie Ventures LLC and a Vice President & Biology at AtheroGenics, Inc. He obtained his undergraduate degree from Drexel University in 1986.
Postes actifs de Charles Kunsch
Sociétés | Poste | Début |
---|---|---|
CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Directeur/Membre du Conseil | 01/04/2024 |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Directeur/Membre du Conseil | 01/09/2021 |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/04/2017 |
Massachusetts Biomedical Initiatives | Directeur/Membre du Conseil | 01/10/2020 |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Directeur/Membre du Conseil | 01/07/2021 |
Dg Medicines
Dg Medicines Pharmaceuticals: MajorHealth Technology Dg Medicines develops medicines and products in various therapeutic areas. | Directeur/Membre du Conseil | 01/12/2021 |
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Directeur/Membre du Conseil | 01/08/2021 |
Penn State Research Foundation
Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Charles Kunsch
Sociétés | Poste | Fin |
---|---|---|
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Private Equity Investor | 01/10/2023 |
░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Charles Kunsch
Drexel University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Health Technology |
Entreprise privées | 9 |
---|---|
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Finance |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Health Technology |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Massachusetts Biomedical Initiatives | |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Health Technology |
Dg Medicines
Dg Medicines Pharmaceuticals: MajorHealth Technology Dg Medicines develops medicines and products in various therapeutic areas. | Health Technology |
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Health Technology |
Penn State Research Foundation
Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | Commercial Services |